AI Article Synopsis

  • - This study explored the link between the EML4-ALK fusion gene and thymidylate synthase (TYMS) expression in non-small cell lung cancer (NSCLC) tissues, analyzing 257 patient samples using quantitative polymerase chain reaction.
  • - It found that the EML4-ALK fusion gene was present in 4.28% of cases, being more common in nonsmokers, while TYMS mRNA was expressed in 63.42% of the samples.
  • - A significant association was observed where lower levels of TYMS mRNA correlated with the presence of the EML4-ALK fusion gene, suggesting that those patients might benefit from treatment with the chemotherapy drug pemetrexed.

Article Abstract

This study aimed to investigate the association of the mRNA expression of the echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) fusion gene with that of thymidylate synthase (TYMS) in non-small cell lung cancer (NSCLC) tissues. Quantitative polymerase chain reaction was used to detect the expression of EML4-ALK fusion gene and TYMS mRNA in 257 cases of NSCLC. The positive rate of EML4-ALK fusion gene was 4.28% in the NSCLC tissues (11/257), and was higher in nonsmokers than in smokers (P<0.05); TYMS mRNA expression was detected in 63.42% (163/257) of cases. An association of the EML4-ALK fusion gene with TYMS expression was detected; a low expression level of TYMS mRNA was observed more frequently when the EML4-ALK fusion gene was present than when it was not detected (P<0.05). In conclusion, patients positive for the EML4-ALK fusion gene in NSCLC tissues are likely to have a low expression level of TYMS, and may benefit from the first-line chemotherapy drug pemetrexed.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473652PMC
http://dx.doi.org/10.3892/etm.2015.2372DOI Listing

Publication Analysis

Top Keywords

fusion gene
16
eml4-alk fusion
12
gene thymidylate
8
thymidylate synthase
8
mrna expression
8
non-small cell
8
cell lung
8
lung cancer
8
nsclc tissues
8
association eml4-alk
4

Similar Publications

Heritable fragile bone disorders (FBDs), ranging from multifactorial to rare monogenic conditions, are characterized by an elevated fracture risk. Validating causative genes and understanding their mechanisms remain challenging. We assessed a semi-high throughput zebrafish screening platform for rapid in vivo functional testing of candidate FBD genes.

View Article and Find Full Text PDF

Gastric cancer is a leading cause of cancer-related deaths globally. As mortality rates continue to rise, predicting cancer survival using multimodal data-including histopathological images, genomic data, and clinical information-has become increasingly crucial. However, extracting effective predictive features from this complex data has posed challenges for survival analysis due to the high dimensionality and heterogeneity of histopathology images and genomic data.

View Article and Find Full Text PDF

Primary renal BCOR::CCNB3 sarcoma in a female patient: case report.

J Pathol Transl Med

January 2025

Department of Pathology, Ulsan University Hospital, Ulsan, Korea.

BCOR-rearranged sarcoma was classified by the World Health Organization in 2020 as a new subgroup of undifferentiated small round-cell sarcoma. It is known to occur very rarely in the kidney. This report presents the first case of a primary renal BCOR::CCNB3 sarcoma in a 22-year-old woman.

View Article and Find Full Text PDF

Objectives: The current research delves into the use of 3D geometric morphometric for assessing shifts in maturity within both the proximal and distal humeral metaphyses. It mainly focuses on establishing correlations between these shifts and the shape changes observed in the corresponding epiphyses established through radiographic imaging.

Material And Methods: The total sample comprises 120 right-side proximal humeral metaphyses and 91 right-side distal humeral metaphyses.

View Article and Find Full Text PDF

The cholangioblastic variant of intrahepatic cholangiocarcinoma is a distinctive neoplasm that typically affects young women without underlying liver disease. Morphologically, it demonstrates solid, trabecular, and tubulocystic architecture, biphasic small cell-large cell cytology, and immunoreactivity for inhibin, neuroendocrine markers, and biliary but not hepatocellular markers. In 2021, our group identified a characteristic NIPBL::NACC1 gene fusion in cholangioblastic cholangiocarcinoma, and since then ~20 genetically confirmed cases have been reported in the literature.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!